Market Overview:
The global harpagide market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising demand for anti-infection drugs, increasing awareness about the benefits of harpagide and growing research and development activities for new applications of harpagide. However, stringent regulatory norms and high cost associated with R&D are some of the major factors restraining the growth of this market. Based on type, more than 98% segment is expected to dominate the global harpagide market during the forecast period from 2018 to 2030. This can be attributed to higher adoption rate of this type as compared to less than 98% type due its advantages such as longer shelf life and better stability over a wide range pH values. Based on application, anti-infection segment is anticipated witness highest growth in terms CAGR over other segments during forecast period from 2018-2030 owing rising prevalence infectious diseases across globe coupled with increasing demand for effective treatment options.
Product Definition:
Harpagide is a glycoside present in the plant genus Harpagophytum. It has anti-inflammatory and analgesic properties.
More than 98%:
The More than 98% is a high purity resin which has over 98.0% of the total composition extracted from Harpagide plant, it's used in pharmaceuticals and nutraceutical industries for making medicines to treat respiratory diseases such as Chronic Obstructive Pulmonary Disease (COPD) and asthma.
Less Than 98%:
The less than 98% is a type of specialty harpagide, which has low moisture content. It is used in the food industry as an ingredient for manufacturing various products such as cheese and butter among others. The less than 98% concentrated harpagide can also be used to produce infant food and nutritional drinks on account of its properties such as promoting growth & development in children under the age of three years.
Application Insights:
The application of harpagide can be categorized into two major segments, which are anti-infective and food and beverages. In terms of revenue, the food and beverage segment dominated the global market with a share of more than 40% in 2017. The growth is attributed to its use in various foods such as cheese, yogurt, ice cream among others. It has been found that this fungus does not grow when exposed to harpagide at concentrations above 1%.
Harpagide acts as an effective antifungal agent against several fungi including Candida albicans (a species predominant yeast responsible for causing candidiasis) which makes it suitable for use in cosmetic products or personal care formulations intended for human skin contact.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period. North America has a large number of manufacturers and suppliers involved in offering products based on harpagoside, which is one of the major factors contributing toward regional growth.
Europe accounted for over 20% share of global revenue in 2017 owing to high demand from countries such as Germany, France, Italy and U.K., where infections are highly prevalent among people causing huge economic losses every year.
Asia Pacific market was valued at USD X million in 2017 due to presence of emerging economies like China.
Growth Factors:
- Increasing awareness about the benefits of harpagide among consumers.
- Growing demand for natural and herbal remedies for various health conditions.
- Rising popularity of traditional Chinese medicine (TCM) in the global market.
- Availability of harpagide in different dosage forms such as capsules, tablets, and powder to suit the needs of consumers.
Scope Of The Report
Report Attributes
Report Details
Report Title
Harpagide Market Research Report
By Type
More than 98%, Less Than 98%
By Application
Anti-Infection, Food and Beverages
By Companies
BLDpharm, Merck, EXTRASYNTHESE, ApexBio Technology, Chengdu Must Bio-Technology, BioCrick BioTech, AdooQ BioScience, ChemScence, Carl ROTH, BOC Sciences, Pharmaffiliates
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
216
Number of Tables & Figures
152
Customization Available
Yes, the report can be customized as per your need.
Global Harpagide Market Report Segments:
The global Harpagide market is segmented on the basis of:
Types
More than 98%, Less Than 98%
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Anti-Infection, Food and Beverages
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- BLDpharm
- Merck
- EXTRASYNTHESE
- ApexBio Technology
- Chengdu Must Bio-Technology
- BioCrick BioTech
- AdooQ BioScience
- ChemScence
- Carl ROTH
- BOC Sciences
- Pharmaffiliates
Highlights of The Harpagide Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- More than 98%
- Less Than 98%
- By Application:
- Anti-Infection
- Food and Beverages
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Harpagide Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Harpagide is a medication used to treat high blood pressure. It works by lowering blood pressure by widening the arteries and reducing the amount of fluid that flows through them.
Some of the major companies in the harpagide market are BLDpharm, Merck, EXTRASYNTHESE, ApexBio Technology, Chengdu Must Bio-Technology, BioCrick BioTech, AdooQ BioScience, ChemScence, Carl ROTH, BOC Sciences, Pharmaffiliates.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Harpagide Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Harpagide Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Harpagide Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Harpagide Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Harpagide Market Size & Forecast, 2020-2028
4.5.1 Harpagide Market Size and Y-o-Y Growth
4.5.2 Harpagide Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 More than 98%
5.2.2 Less Than 98%
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Anti-Infection
6.2.2 Food and Beverages
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Harpagide Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Harpagide Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 More than 98%
9.6.2 Less Than 98%
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Anti-Infection
9.10.2 Food and Beverages
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 More than 98%
10.6.2 Less Than 98%
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Anti-Infection
10.10.2 Food and Beverages
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 More than 98%
11.6.2 Less Than 98%
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Anti-Infection
11.10.2 Food and Beverages
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 More than 98%
12.6.2 Less Than 98%
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Anti-Infection
12.10.2 Food and Beverages
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 More than 98%
13.6.2 Less Than 98%
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Anti-Infection
13.10.2 Food and Beverages
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Harpagide Market: Competitive Dashboard
14.2 Global Harpagide Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 BLDpharm
14.3.2 Merck
14.3.3 EXTRASYNTHESE
14.3.4 ApexBio Technology
14.3.5 Chengdu Must Bio-Technology
14.3.6 BioCrick BioTech
14.3.7 AdooQ BioScience
14.3.8 ChemScence
14.3.9 Carl ROTH
14.3.10 BOC Sciences
14.3.11 Pharmaffiliates
